General Information of This Metabolic Reaction (MR) (ID: MR001213)
Formula Reactant Irbesartan derivative M7 Product Irbesartan derivative M1
Reactant Info Product Info
Metabolic Enzyme Cytochrome P450 2C9 (CYP2C9) DME Info
Metabolic Type Oxidation - Hydroxylation
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Produce The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001217 Irbesartan Irbesartan derivative M7 Oxidation - Hydroxylation Irbesartan [1], [2]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001209 Irbesartan derivative M4 Irbesartan derivative M1 Oxidation - Hydroxylation Irbesartan [2]
MR001212 Irbesartan derivative M5 Irbesartan derivative M1 Oxidation - Hydroxylation Irbesartan [2]
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001211 Irbesartan derivative M1 Irbesartan derivative M2 Oxidation - Oxidation Irbesartan [2]
References
1 Biotransformation of irbesartan in man Drug Metab Dispos. 1998 May;26(5):408-17.
2 Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.